| Value | ₹1,138 Cr |
|---|
BSE filing, NSE: NRAIL. Summary written from the filing by ALFA Finder's alert engine.
N R Agarwal Industries Ltd: key numbers
- Share price
- ₹686.05
- Market cap
- ₹1,168 Cr
- Revenue (annual)
- ₹2,145 Cr
- Net profit (annual)
- ₹43.70 Cr
- P/E (TTM)
- 18.8×Sector 45.2×
- Promoter holding
- 74.29%+0.00% QoQ
- FII holding
- 0.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from N R Agarwal Industries Ltd
All →N R Agarwal Industries Board Meeting Date
NR Agarwal Industries scheduled a board meeting for 03 Nov 2026 to approve unaudited results for Q1 and H1 FY27. No financial figures are disclosed in this advance intimation.
N R Agarwal Industries Other Announcement
NR Agarwal Industries Ltd submitted its quarterly shareholding pattern report as required under Regulation 31(1)(b) of SEBI listing norms.
N R Agarwal Industries Management Change
NR Agarwal Industries appoints Mr. Makarand P Barhanpurkar as Director – Operations & Project effective October 12, 2026. He brings 36+ years of paper industry experience from ITC.
N R Agarwal Industries Price Movement Clarification
N R Agarwal Industries clarified to NSE that its stock's significant price movement is purely market-driven. No undisclosed event or impending announcement exists.
N R Agarwal Industries Annual General Meeting
N R Agarwal Industries held its 33rd Annual General Meeting on September 2, 2026. Shareholders approved all resolutions, including borrowing power increases and dividend declarations.
N R Agarwal Industries Management Change
N R Agarwal Industries has appointed Mr. Manoj Chauhan as Chief Marketing & Business Transformation Officer, effective September 01, 2026.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.